Agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab’s antibody discovery platform. CAMBRIDGE, England, Jan. 9, 2025 /PRNewswire/ — Alchemab Therapeutics (Alchemab), a biopharmaceutical company aiming to identify and…